21 CFR · Food and Drugs
§ 226.42 — Components.
21 CFR § 226.42
TitleTitle 21: Food and DrugsPartPart 226: Current Good Manufacturing Practice for Type a Medicated Articles
SourceeCFR (current through Apr 9, 2026)
This text of 21 C.F.R. § 226.42 (Components.) is published on Counsel Stack Legal Research, covering United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
21 C.F.R. § 226.42 (2026).
Text
§ 226.42 Components.
(a)Drug components, including undiluted drugs and any intermediate mixes containing drugs used in the manufacture and processing of Type A medicated article(s), shall be received, examined or tested, stored, handled, and otherwise controlled in a manner to maintain the integrity and identification of such articles. Appropriate receipt and inventory records shall be maintained for 2 years, and such records shall show the origin of any drug components, the manufacturer's control number (if any), the dates and batches in which they were used, and the results of any testing of them.
(b)Nondrug components shall be stored and otherwise handled in a manner to avoid contamination, including cross-contamination from manufacturing operations.
Free access — add to your briefcase to read the full text and ask questions with AI
Nearby Sections
11
§ 226.10
Personnel.§ 226.20
Buildings.§ 226.30
Equipment.§ 226.42
Components.§ 226.58
Laboratory controls.§ 226.80
Packaging and labeling.§ 226.110
Distribution records.§ 226.115
Complaint files.Cite This Page — Counsel Stack
Bluebook (online)
21 C.F.R. § 226.42, Counsel Stack Legal Research, https://law.counselstack.com/cfr/21/226/226.42.